Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial

American Journal of Cardiology

Volumn 87, Issue 4, 2001, Pages 397-400

  Schühlen, Helmut ^a   Kastrati, Adnan ^a   Pache, Jürgen ^a   Dirschinger, Josef ^a   Schömig, Albert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PHENPROCOUMON; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENPROCOUMON; PLATELET AGGREGATION INHIBITORS; RECURRENCE; STATISTICS, NONPARAMETRIC; STENTS; SURVIVAL ANALYSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0035865622     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01390-4     Document Type: Article

References (16)

1. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
2. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: Six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial
3. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation
4. Continued benefit of coronary stenting versus balloon angioplasty: One-year clinical follow-up of Benestent trial
5. Three-year follow-up after implantation of metallic coronary-artery stents
6. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: Paucity of late clinical stent-related problems
7. Three-year clinical follow-up after Palmaz-Schatz stenting
8. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: Analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial
9. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting
10. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study
11. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
12. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): A four-year follow-up
13. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of BENESTENT-I trial
14. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure
15. Stent restenosis: Can effective antithrombotic therapy be protective?
16. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial